Mico Biomed Co., Ltd.
South KoreaFDA applicant, unverified
- Devices
- 2
What Mico Biomed Co., Ltd. makes
Mico Biomed Co., Ltd. makes blood glucose monitoring systems, including the VERI-Q and VERI-Q PLUS models. These systems are used for self-testing and monitoring blood glucose levels.
The company's portfolio is regulated as Class II devices and is listed in the FDA 510(k) registry. Mico Biomed Co., Ltd. is based in the US.
Catalogue
Veri-Q Mgd-1001 Blood Glucose Monitoring System, Veri-Q Plus Mgd-1001 Blood Glucose Monitoring System Ref K123007
Regimes: 510(k) Registry: 510(k)- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Mico Biomed Co., Ltd. have in the registry?
The registry currently lists 2 devices for Mico Biomed Co., Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Mico Biomed Co., Ltd.'s devices?
Among its 2 most recently registered devices, Mico Biomed Co., Ltd. has devices listed in FDA 510(k) (2 devices).
What risk classes do Mico Biomed Co., Ltd.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Mico Biomed Co., Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Mico Biomed Co., Ltd. in the registry?
The most recently registered devices listed for Mico Biomed Co., Ltd. include VERI-Q MGD-1001 BLOOD GLUCOSE MONITORING SYSTEM, VERI-Q PLUS MGD-1001 BLOOD GLUCOSE MONITORING SYSTEM and VERI-Q SELF-TESTING AND VERI-Q PLUS MGD-2001 BLOOD GLUCOSE MONITORING SYSTEMS.